Aortic valve replacement
KEYWORDS: valve, patients, evidence, level, level evidence, patient, avr, valves, surgery, risk, mechanical, replacement, class, warfarin, tissue

first 3 months after AVR with a mechanical prosthesis, it is reasonable to give warfarin to achieve an INR of 2.5 to 3.5. (Level of Evidence C)" "2. During the first 3 months after AVR or MV replacement with a bioprosthesis, in patients with no risk factors,* it is reasonable to give warfarin to achieve an INR of 2.0 to 3.0. (Level of Evidence C)" * Risk factors include atrial fibrillation, previous thromboembolism, LV dysfunction, and hypercoagulable condition. “ ” Intraoperative Assessment (DO NOT EDIT) [1] Class I "1. Intraoperative transesophageal echocardiography is recommended for valve replacement surgery with a stentless xenograft, homograft, or autograft valve. (Level of Evidence B)" 3/5 Class IIa "1. Intraoperative transesophageal echocardiography is reasonable for all patients undergoing cardiac valve surgery. (Level of Evidence C)" Follow-Up Visits in Patients With Complications (DO NOT EDIT) [2] Class I "1. Patients with LV systolic dysfunction after valve surgery should receive standard medical therapy for systolic heart failure. This therapy should be continued even if there is improvement of LV dysfunction. (Level of evidence B)" Treatment of Coronary Artery Disease (DO NOT EDIT) [2] Class I "1. Patients undergoing AVR with significant stenoses (greater than or equal to
